Trials / Completed
CompletedNCT02066805
Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 142 (actual)
- Sponsor
- Amgen · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate off-label XGEVA use in Denmark using data linked from registries and other sources in Northern Jutland Region and Copenhagen. This will allow for accurate assessment of prescriptions and diagnoses, especially those related to cancer patients during the first year post the initial market availability of XGEVA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Database assessment of off-label XGEVA use | No intervention is planned during this study as it involves analyses of patient electronic records from Northern Jutland Region and Copenhagen |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-02-20
- Last updated
- 2015-05-29
Source: ClinicalTrials.gov record NCT02066805. Inclusion in this directory is not an endorsement.